Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:CTXAFNYSE:PKI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCTXAFAmpol$16.30$15.97$14.46▼$23.51N/AN/A14,550 shsN/APKIRevvity$127.73$113.46▼$170.00$14.57B1.1851,117 shs1.63 million shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCTXAFAmpol0.00%0.00%0.00%+12.72%-17.93%PKIRevvity0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCTXAFAmpolN/AN/AN/AN/AN/AN/AN/AN/APKIRevvity3.832 of 5 stars0.00.01.73.50.61.74.4Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCTXAFAmpol 0.00N/AN/AN/APKIRevvity 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCTXAFAmpolN/AN/AN/AN/AN/AN/APKIRevvity$3.31B0.00N/A9.88$58.49 per share0.00Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCTXAFAmpolN/A$1.848.84∞N/AN/AN/AN/A8/18/2025 (Estimated)PKIRevvity$569.18M$7.6815.010.000.5028.94%11.17%5.83%N/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCTXAFAmpol$0.171.04%N/A9.22%N/APKIRevvity$0.280.24%N/A3.65%N/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCTXAFAmpolN/AN/AN/APKIRevvity0.482.432.15Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCTXAFAmpol10.16%PKIRevvity85.22%Insider OwnershipCompanyInsider OwnershipCTXAFAmpolN/APKIRevvity0.52%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCTXAFAmpol9,000N/AN/ANot OptionablePKIRevvity16,700126.41 million125.76 millionOptionableDCC, PKI, VVO, HYR, and CTXAF HeadlinesRecent News About These CompaniesWhat 9 Analyst Ratings Have To Say About RevvityJune 28, 2025 | benzinga.comRevvity, formerly PerkinElmer, moves to newer, smaller Waltham HQNovember 29, 2024 | bostonglobe.comBRevvity Ramps Up R&D Spending Since PerkinElmer SplitOctober 15, 2024 | msn.comRevvity, Inc. (RVTY)July 19, 2024 | finance.yahoo.comRevvity Inc PKIFebruary 13, 2024 | morningstar.comMRevvity revenue drops 17% in first year after PerkinElmer spinout, thanks to COVID testing declinesFebruary 1, 2024 | fiercebiotech.comFPerkinElmer buys Covaris to boost next-gen life sciences offeringsDecember 4, 2023 | mmm-online.comMPerkinElmer picks up Covaris’ sample prep portfolio in New Mountain-led dealDecember 4, 2023 | fiercebiotech.comFRevvity Launches EONIS Q System Enabling Faster, Simplified Newborn Screening for SMA and SCIDDecember 1, 2023 | businesswire.comRevvity and Sciex Collaborate To Provide Innovative Neonatal Mass Spectrometry SolutionNovember 1, 2023 | technologynetworks.comTRevvity Stock (NYSE:RVTY), Analyst Ratings, Price Targets, PredictionsNovember 1, 2023 | benzinga.comRevvity, Inc. and Element Biosciences, Inc. Pioneer Next-Generation Sequencing Kits Market with Innovative Genomic Analysis SolutionsOctober 29, 2023 | finance.yahoo.comRevvity, IncAugust 3, 2023 | moneycontrol.comRevvity (RVTY) Beats on Q2 Earnings, Lowers '23 EPS ViewAugust 2, 2023 | finance.yahoo.comRevvity (NYSE: PKI)August 1, 2023 | fool.comRevvity (RVTY) to Report Q2 Earnings: What's in the Cards?July 31, 2023 | finance.yahoo.comPerkinElmer Completes Transformation to Become RevvityMay 19, 2023 | finance.yahoo.comRevvity Announces New License Agreement for Next-Generation Base Editing TechnologyMay 18, 2023 | finance.yahoo.comJ.P. Morgan Keeps Their Hold Rating on PerkinElmer (PKI)May 16, 2023 | markets.businessinsider.comCitigroup Maintains Revvity (PKI) Buy RecommendationMay 15, 2023 | msn.comDCC, PKI, VVO, HYR, and CTXAF Company DescriptionsAmpol OTCMKTS:CTXAF$16.30 0.00 (0.00%) As of 07/3/2025Ampol Limited purchases, refines, distributes, and markets petroleum products in Australia, New Zealand, Singapore, and the United States. The company operates through Convenience Retail, Z Energy, and Fuels and Infrastructure segments. The Convenience Retail segment sells fuels through Ampol's network of stores. The Fuels and Infrastructure segment wholesales fuels and lubricant supplies. The Z Energy segment distributes fuel in the New Zealand market. It distributes its products through depots, terminals, pipelines, and service station sites. The company sells fuels to various customers in defense, mining, transport, marine, agriculture, aviation, and other commercial and industrial sectors. The company was formerly known as Caltex Australia Limited and changed its name to Ampol Limited in May 2020. The company was founded in 1900 and is headquartered in Alexandria, Australia.Revvity NYSE:PKIRevvity, Inc provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. It focuses on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics.? The company was founded by Richard Scott Perkin and Charles W. Elmer on April 19, 1937, and is headquartered in Waltham, MA. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/30 - 07/04 The Apple Comeback Will Be Better Than the Setback Micron’s Big Q3 Drives Applied Materials’ Bullish Outlook Why Occidental's Price Dip Signals a Buying Opportunity Qualcomm’s Hold Rating Misses Strong Growth Story Rigetti Computing: Cantor's Bullish Call May Be Just the Start Insider Selling at NVIDIA Could Turn Into an Opportunity Whiplash for Investors: AeroVironment's Confusing Stock Signals Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
